| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 8 | JP 1 | 99.82 |
| Noise Effects and Management | Lifetime | 32 | JP 1 | 99.46 |
| Carbon Nanotubes in Composites | Lifetime | 52 | JP 4 | 99.68 |
| Diamond and Carbon-based Materials Research | Lifetime | 92 | JP 11 | 99.34 |
| Graphene research and applications | Lifetime | 170 | JP 10 | 99.57 |
| Dermatological and Skeletal Disorders | Lifetime | 24 | JP 2 | 99.13 |
| Parathyroid Disorders and Treatments | Lifetime | 108 | JP 6 | 99.09 |
| Peptidase Inhibition and Analysis | Lifetime | 309 | JP 14 | 98.75 |
| Cancer therapeutics and mechanisms | Lifetime | 183 | JP 12 | 98.87 |
| Adhesion, Friction, and Surface Interactions | Lifetime | 119 | JP 3 | 98.55 |
| Acoustic Wave Phenomena Research | Lifetime | 123 | JP 1 | 98.51 |
| Sarcoidosis and Beryllium Toxicity Research | Lifetime | 75 | JP 2 | 98.77 |
| Force Microscopy Techniques and Applications | Lifetime | 252 | JP 11 | 98.61 |
| T-cell and Retrovirus Studies | Lifetime | 136 | JP 24 | 98.30 |
| Nanotechnology research and applications | Lifetime | 34 | JP 4 | 98.04 |
| Fullerene Chemistry and Applications | Lifetime | 142 | JP 32 | 98.14 |
| Vehicle Noise and Vibration Control | Lifetime | 74 | JP 1 | 97.72 |
| Cellular transport and secretion | Lifetime | 305 | JP 18 | 98.26 |
| Medical Imaging and Pathology Studies | Lifetime | 412 | JP 43 | 97.78 |
| Neuroendocrine Tumor Research Advances | Lifetime | 534 | JP 38 | 98.20 |
| Drug Transport and Resistance Mechanisms | Lifetime | 561 | JP 41 | 97.67 |
| Alzheimer's disease research and treatments | Lifetime | 606 | JP 21 | 98.49 |
| Cancer Treatment and Pharmacology | Lifetime | 664 | JP 15 | 98.25 |
| Electrolyte and hormonal disorders | Lifetime | 263 | JP 10 | 97.33 |
| Semiconductor Lasers and Optical Devices | Lifetime | 861 | JP 121 | 97.73 |
| Lung Cancer Research Studies | Lifetime | 687 | JP 58 | 97.71 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | Lifetime | 386 | JP 20 | 96.92 |
| Hearing Loss and Rehabilitation | Lifetime | 423 | JP 3 | 97.59 |
| Trace Elements in Health | Lifetime | 598 | JP 18 | 96.80 |
| Vector-Borne Animal Diseases | Lifetime | 440 | JP 49 | 97.30 |
| Animal Disease Management and Epidemiology | Lifetime | 640 | JP 42 | 97.05 |
| Pancreatitis Pathology and Treatment | Lifetime | 803 | JP 110 | 96.92 |
| Fatty Acid Research and Health | Lifetime | 530 | JP 21 | 96.39 |
| Pneumocystis jirovecii pneumonia detection and treatment | Lifetime | 645 | JP 4 | 96.93 |
| Lipid metabolism and disorders | Lifetime | 338 | JP 15 | 96.31 |
| Neonatal Health and Biochemistry | Lifetime | 595 | JP 31 | 96.15 |
| Neutropenia and Cancer Infections | Lifetime | 467 | JP 9 | 96.15 |
| Protein Kinase Regulation and GTPase Signaling | Lifetime | 587 | JP 52 | 96.23 |
| Eosinophilic Disorders and Syndromes | Lifetime | 675 | JP 44 | 95.45 |
| Music Technology and Sound Studies | Lifetime | 308 | JP 8 | 95.57 |
| Blood properties and coagulation | Lifetime | 663 | JP 29 | 94.79 |
| IgG4-Related and Inflammatory Diseases | Lifetime | 202 | JP 86 | 93.69 |
| Ion Transport and Channel Regulation | Lifetime | 655 | JP 44 | 94.88 |
| Dental Health and Care Utilization | Lifetime | 844 | JP 35 | 95.44 |
| Chemotherapy-induced organ toxicity mitigation | Lifetime | 197 | JP 6 | 92.78 |
| Fibroblast Growth Factor Research | Lifetime | 641 | JP 58 | 92.59 |
| Laser Applications in Dentistry and Medicine | Lifetime | 682 | JP 24 | 93.16 |
| Amyotrophic Lateral Sclerosis Research | Lifetime | 686 | JP 59 | 93.49 |
| Cerebrovascular and genetic disorders | Lifetime | 202 | JP 16 | 92.25 |
| Myasthenia Gravis and Thymoma | Lifetime | 855 | JP 102 | 91.62 |
| Neuroscience and Music Perception | Lifetime | 972 | JP 20 | 91.58 |
| Autoimmune Neurological Disorders and Treatments | Lifetime | 604 | JP 55 | 87.42 |
| Calpain Protease Function and Regulation | Lifetime | 406 | JP 67 | 85.79 |
| Methemoglobinemia and Tumor Lysis Syndrome | Lifetime | 323 | JP 21 | 81.03 |
| Aortic Thrombus and Embolism | Lifetime | 712 | JP 120 | 66.71 |
| Paraquat toxicity studies and treatments | Lifetime | 965 | JP 90 | 45.45 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | 2021-2025 | 60 | JP 3 | 97.39 |
| Parathyroid Disorders and Treatments | 2021-2025 | 478 | JP 43 | 87.10 |
| Sarcoidosis and Beryllium Toxicity Research | 2021-2025 | 321 | JP 32 | 85.65 |
| Protein Kinase Regulation and GTPase Signaling | 2021-2025 | 211 | JP 11 | 72.75 |
| Cerebrovascular and genetic disorders | 2021-2025 | 494 | JP 34 | 49.12 |
| Chemotherapy-induced organ toxicity mitigation | 2021-2025 | 684 | JP 25 | 43.00 |
| Dermatological and Skeletal Disorders | 2021-2025 | 879 | JP 38 | 37.24 |